Trade

with

ResMed Inc
(NYSE: RMD)
AdChoices
47.70
+0.20
+0.42%
After Hours :
49.00
+1.30
+2.73%

Open

47.60

Previous Close

47.50

Volume (Avg)

1.16M (982.75k)

Day's Range

47.46-48.10

52Wk Range

41.52-56.70

Market Cap.

6.69B

Dividend Rate (Yield )

1.12 (2.16%)

Beta

0.82

Shares Outstanding

139.75M

P/E Ratio (EPS)

19.96 (2.39)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 1.55B

    • Net Income

    • 345.27M

    • Market Cap.

    • 6.69B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 22.20

    • PEG (Price/Earnings Growth) Ratio

    • 3.97

    • Beta

    • 0.82

    • Forward P/E

    • 41.32

    • Price/Sales

    • 4.43

    • Price/Book Value

    • 3.80

    • Price/Cash flow

    • 17.61

      • EBITDA

      • 510.66M

      • Return on Capital %

      • 15.10

      • Return on Equity %

      • 20.50

      • Return on Assets %

      • 15.10

      • Book Value/Share

      • 12.54

      • Shares Outstanding

      • 139.75M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.28 (11/18/2014)

      • Dividend Declaration Date

      • 10/23/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 39.00

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • 1.74

        • Cashflow Estimate

        • 2.79

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.10

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • 12.40

          • -15.59

          • Net Income

            Q/Q (last year)

          • 20.20

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 11.05

          • 12.51

          • Net Income

            5-Year Annual Average

          • 18.70

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 63.65

            • 52.83

            • Pre-Tax Margin

            • 27.72

            • 15.96

            • Net Profit Margin

            • 22.20

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 61.10

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 25.10

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 19.40

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.17

              • 0.62

              • Current Ratio

              • 5.77

              • 1.97

              • Quick Ratio

              • 4.75

              • 1.16

              • Interest Coverage

              • 71.33

              • 10.47

              • Leverage Ratio

              • 1.34

              • 2.38

              • Book Value/Share

              • 12.54

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 19.96

                • 35.97

                • P/E Ratio 5-Year High

                • 23.97

                • 279.76

                • P/E Ratio 5-Year Low

                • 9.77

                • 148.87

                • Price/Sales Ratio

                • 4.43

                • 3.33

                • Price/Book Value

                • 3.80

                • 4.16

                • Price/Cash Flow Ratio

                • 17.61

                • 17.27

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 20.50

                    (17.10)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 15.10

                    (13.20)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 17.64

                    (15.30)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 84.21k

                  • 25.65k

                  • Inventory Turnover

                  • 3.63

                  • 2.66

                  • Asset Turnover

                  • 0.68

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  405.09M
                  Operating Margin
                  26.05
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  17.61
                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Aggressive Growth

                  Style

                  Mid Core

                  ResMed Inc a Delaware corporation was formed in March 1994. The Company is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders...more, with a focus on sleep-disordered breathing, or SDB. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. The Company markets its products in more than 100 countries to sleep clinics, home healthcare dealers and third-party payors. It also market the products directly to sleep clinics. The Company’s portfolio of products includes airflow generators, diagnostic products, mask systems, headgear and other accessories. The...more Company produces CPAP, VPAP and AutoSet systems for the titration and treatment of SDB. The flow generator systems deliver positive airway pressure through a patient interface, either a small nasal mask, nasal pillows system, or full-face mask. The Company’s competitors include Philips BV; DeVilbiss Healthcare; Fisher & Paykel Healthcare Corporation Limited; Apex Medical Corporation; BMC Medical Co. Ltd.; and regional manufacturers. The Company’s products are subject to extensive regulation particularly as to safety, efficacy and adherence to FDA Quality System Regulation, and related manufacturing standards. Medical device products are subject to rigorous FDA and other governmental agency regulations in the United States and similar regulations of foreign agencies abroad.lessless

                  Key People

                  Mr. Michael J. Farrell

                  CEO/Director

                  Dr. Peter C. Farrell,PhD

                  Chairman of the Board/Founder

                  Mr. Brett Sandercock

                  CFO/Chief Accounting Officer

                  Dr. Christopher G. Roberts,PhD

                  Director

                  Dr. Gary W. Pace,PhD

                  Director

                  • ResMed Inc

                  • 9001 Spectrum Center Boulevard

                  • San Diego, CA 92123

                  • USA.Map

                  • Phone: +1 858 836-5000

                  • Fax: -

                  • resmed.com

                  Incorporated

                  1994

                  Employees

                  4,100